Clinical research of Lucentis combined with fortify spleen for fluid retention removement recipe in the treatment of retinal vein occlusion macular edema
Objective To explore the clinical effects of Lucentis combined with fortify spleen for fluid retention remove-ment recipe and its prognostic indicators in the treatment of retinal vein occlusion macular edema(RVO-ME).Methods A total of 60 patients with RVO-ME visiting the First Affiliated Hospital of Zhejiang Chinese Medical University from Octo-ber 2021 to October 2022 were randomly divided into a combination treatment group and a conventional treatment group.Each included 30 cases.All patients were given intravitreal injection of Ranibizumab for three months.The combined treat-ment group was given oral granules administration of self-prepared Chinese medicine recipe for fortifying spleen to remove fluid retention,while the control group was treated with placebo granules.The inflammatory markers of peripheral blood,best corrected visual acuity(BCVA),high reflection signal(HRF)in OCT images,macular central thickness(CMT),sub-retinal fluid(SRF),and cystoid macular edema(CME)before and after the treatment in the two groups were com-pared.Those indexes were also compared between patients with and without recurrent ME,The group with recurrent ME in-cluded 20 patients,while the group without recurrent ME included 40 patients.Results After 3 months of treatment,the systemic immune inflammatory index(SII),neutrophil-to-lymphocyte ratio(NLR),HRF,and CMT in the combined treat-ment group were significantly lower than those in the conventional treatment group(P＜0.05).The combined treatment group has significantly higher resolution rates of SRF(88.9％vs.50.0％)and CME(63.0％vs.25.0％,P＜0.05).The RVO-ME recurrence rate in the combined treatment group was 20.0％,significantly lower than the conventional group(46.7％,P＜0.05).HRF and CMT descended more significantly in patients without recurrent ME than those with recurrent ME(P＜0.05).The ROC curve indicates patients with baseline CMT＜497.50 μm(P=0.010)and HRF＜15.5(P=0.021)had a lower probability of edema recurrence and better BCVA.Conclusion Combined treatment of Lucentis with self-prepared Chinese medicine granules improves the efficacy and reduces recurrence in the treatment of RVO-ME.Pa-tients with CMT＜497.50 μm and HRF≤15 before treatment have a better prognosis.
Retinal vein occlusion macular edemaOptical coherence tomographyTreatment responseGranule of tradi-tional Chinese medicineBiomarkers
维普
万方数据
